Tablet Press Increases Output - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Tablet Press Increases Output



The Manesty TPR 500 tablet press from Bosch Packaging Technology features enhancements such as a die table, torque drive and tablet discharge chute, and a human machine interface (HMI).

The TPR 500 is equipped with a new 56-station die table and can produce more than 400,000 tablets per hour. The modular powder feeding system allows for more flexibility with a two-paddle design that can be upgraded to three paddles, depending on product properties and powder characteristics. In addition, the True Flow tablet discharge chute features a pneumatic gate mechanism and an improved take-off angle, helping to reduce product damage and increase output, particularly with shaped or friable tablets.

Connected directly to the turret, the Siemens torque drive achieves high torque at low rpm while saving space in the mechanical area. Turret removal is possible in 10 minutes, while complete product changeover can be achieved in less than one hour. The hygienic design of the Manesty TPR 500, allows production to be separate from the mechanical area, preventing powder contamination in the mechanical zone.

The tablet press was introduced at Interpack 2014.

Source: Bosch Packaging Technology

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here